Patents by Inventor Alexander Josef Wurzer

Alexander Josef Wurzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DUAL MODE RADIOTRACER AND -THERAPEUTICS
    Publication number: 20240066155
    Abstract: The present invention relates to compounds of the Formula (1) and pharmaceutically acceptable salts thereof, wherein M3+ is as defined herein, and their use as cancer diagnostic or imaging agents.
    Type: Application
    Filed: January 4, 2022
    Publication date: February 29, 2024
    Inventors: Hans-Jürgen WESTER, Alexander Josef WURZER, Matthias Johannes EIBER
  • DUAL MODE RADIOTRACER AND -THERAPEUTICS
    Publication number: 20220370649
    Abstract: The present invention relates to a ligand-SIF A-chelator conjugate, comprising, within in a single molecule three separate moieties: (a) one or more ligands which are capable of binding to a disease-relevant target molecule, (b) a silicon-fluoride acceptor (SIFA) moiety which comprises a covalent bond between a silicon atom and a fluorine atom, and (c) one or more chelating groups, optionally containing a chelated nonradioactive or radioactive cation.
    Type: Application
    Filed: June 24, 2022
    Publication date: November 24, 2022
    Inventors: Alexander Josef Wurzer, Hans-Jürgen Wester, Matthias Johannes Eiber
  • Dual mode radiotracer and—therapeutics
    Patent number: 11413360
    Abstract: The present invention relates to a ligand-SIFA-chelator conjugate, comprising, within in a single molecule three separate moieties: (a) one or more ligands which are capable of binding to a disease-relevant target molecule, (b) a silicon-fluoride acceptor (SIFA) moiety which comprises a covalent bond between a silicon atom and a fluorine atom, and (c) one or more chelating groups, optionally containing a chelated nonradioactive or radioactive cation.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: August 16, 2022
    Assignees: Technische Universität München, Technische Universität München—Klinikum Rechts der Isar
    Inventors: Alexander Josef Wurzer, Hans-Jürgen Wester, Matthias Johannes Eiber
  • CANCER DIAGNOSTIC IMAGING AGENTS
    Publication number: 20220118120
    Abstract: The present invention relates to a ligand-SIFA-chelator conjugate, comprising, within a single molecule three separate moieties: (a) one or more ligands which are capable of binding to PSMA, (b) a silicon-fluoride acceptor (SIFA) moiety which comprises a covalent bond between a silicon atom and a fluorine atom, and (c) one or more chelating groups, containing a chelated nonradioactive cation.
    Type: Application
    Filed: January 30, 2020
    Publication date: April 21, 2022
    Inventors: Alexander Josef Wurzer, Hans-Jürgen Wester, Matthias Johannes Eiber
  • PSMA BINDING DUAL MODE RADIOTRACER AND THERAPEUTIC
    Publication number: 20220096668
    Abstract: The present invention relates to a compound according to formula (V): or a pharmaceutically acceptable salt thereof, optionally containing a chelated radioactive cation and wherein F is optionally 18F.
    Type: Application
    Filed: January 30, 2020
    Publication date: March 31, 2022
    Inventors: Alexander Josef Wurzer, Hans-Jürgen Wester, Matthias Johannes Eiber
  • DUAL MODE RADIOTRACER AND -THERAPEUTICS
    Publication number: 20200197545
    Abstract: The present invention relates to a ligand-SIFA-chelator conjugate, comprising, within in a single molecule three separate moieties: (a) one or more ligands which are capable of binding to a disease-relevant target molecule, (b) a silicon-fluoride acceptor (SIFA) moiety which comprises a covalent bond between a silicon atom and a fluorine atom, and (c) one or more chelating groups, optionally containing a chelated nonradioactive or radioactive cation.
    Type: Application
    Filed: July 30, 2018
    Publication date: June 25, 2020
    Inventors: Alexander Josef Wurzer, Hans-Jürgen Wester, Matthias Johannes Eiber